Friday, April 30, 2021 3:00 - 4:00 PM EDT
Maximizing Repositories to Accelerate ALS Research: Biofluids, Tissues, Cells and Data
Register here
After registering, you will receive a confirmation email containing information about joining the webinar.
Many types of Biorepositories and related efforts exist to support research and to aid in therapeutic development. We invite you to join us for this webinar and learn more about how ALS biorepositories can aid in your research efforts. The one-hour webinar will provide an overview of the Biorepositories and the process for requesting and obtaining samples.
Wednesday, May 5, 2021 1:00 PM - 2:00 PM EDT
ALS Drug Development Webinar Series: Ethical Considerations
Register here
After registering, you will receive a confirmation email containing information about joining the webinar.
In this webinar, Dr. Simmons will discuss the ethical issues surrounding informed consent, placebo controls, placebo-to-drug ratio, “fairness” of inclusion/exclusion criteria and patient selection, remote vs. in-person visits, open-label extensions, expanded access and "Right to Try" pathways.
Friday, May 14, 2021 3:30 PM - 4:30 PM EDT
ALS Drug Development Webinar Series: Site Considerations
Register here
After registering, you will receive a confirmation email containing information about joining the webinar.
In this webinar, Drs. Nicholson and Babu will discuss some of the issues faced by sites in a clinical trial including the specific steps and resources a site needs to open and run a clinical trial and an expanded access program.
Monday, May 17, 2021 2:00 PM - 3:00 PM EDT
An Update on the CENTAUR Trial: a Trial of AMX0035 in ALS
Register here
After registering, you will receive a confirmation email containing information about joining the webinar.
Join us for a conversation about the results of this trial and the next steps for AMX0035.
Tuesday, May 18, 2021 3:00 - 4:00 PM EDT
REFINE-ALS: Finding Biomarkers of Edaravone (Radicava) Effect - From the Comfort of Your Home
Register here
After registering, you will receive a confirmation email containing information about joining the webinar.
Dr. James Berry (primary investigator) will review the importance of biomarkers and the REFINE-ALS study, provide a study status update, discuss recent changes to the study, including the option for remote study visits. We hope you will join us to learn more about REFINE-ALS and how to get involved.
Mon, Jun 7, 2021 5:00 - 6:00 PM EDT
ALS Clinical Trial Pipeline
Register here
After registering, you will receive a confirmation email containing information about joining the webinar.
Dr. Merit Cudkowicz will review the ALS clinical trial pipeline and answers questions about the current state of clinical research.
Past ALS Association/NEALS Webinars
